ZEVRA THERAPEUTICS, INC. Item 1.01 Entry into a Material Definitive Agreement.
Warrant Exercise Inducement Letters and Issuance of Warrants
As previously reported, on
On
The Company also agreed to file a registration statement covering the resale of the shares of the Company's common stock issued or issuable upon the exercise of the Inducement Warrants no later than 10 calendar days following the date of the Inducement Letters.
--------------------------------------------------------------------------------
Inducement Warrant Terms
The following summary of certain terms and provisions of the Inducement Warrants is not complete and is subject to, and qualified in its entirety by, the provisions of the Inducement Warrants, the form of which is filed as Exhibit 4.1 to this Current Report on Form 8-K and is incorporated herein by reference. The following description of the Inducement Warrants is qualified in its entirety by reference to such exhibit.
Duration and Exercise Price
The Inducement Warrants are exercisable from and after the date of their
issuance and expire on
Exercisability
The Inducement Warrants will be exercisable, at the option of each holder, in whole or in part, by delivering to the Company a duly executed exercise notice, provided that payment in full for the number of shares of the Company's common stock purchased upon such exercise is delivered to the Company in accordance with the terms of the Inducement Warrants (except in the case of a cashless exercise as discussed below). A holder (together with its affiliates) may not exercise any portion of the Inducement Warrant to the extent that the holder and its affiliates and any other person or entities with which such holder would constitute a Section 13(d) "group" would own more than 4.99% (or, upon election by a holder prior to the issuance of its Inducement Warrants, 9.99%) of the Company's outstanding common stock immediately after exercise.
Cashless Exercise
If, at the time a holder exercises its Inducement Warrants, a registration statement registering the issuance of the shares of common stock underlying such Inducement Warrant under the Securities Act is not then effective or available for the issuance of such shares, then in lieu of making the cash payment otherwise contemplated to be made to the Company upon such exercise in payment of the aggregate exercise price, the holder may elect instead to receive upon such exercise (either in whole or in part) the net number of shares of common stock determined according to a formula set forth in the Inducement Warrants.
Right as a Stockholder
Except as otherwise provided in the Inducement Warrants or by virtue of such holder's ownership of shares of the Company's common stock, the holders of the Inducement Warrants do not have the rights or privileges of holders of common stock with respect to the shares of common stock underlying the Inducement Warrants, including any voting rights, until they exercise their Inducement Warrants. The Inducement Warrants provide that holders have the right to participate in distributions or dividends paid on the Company's common stock.
Fundamental Transaction
In the event of a fundamental transaction, as described in the Inducement Warrants and generally including any reorganization, recapitalization or reclassification of the Company's common stock, the sale, transfer or other disposition of all or substantially all of the Company's properties or assets, the Company's consolidation or merger with or into another person, the acquisition of more than 50% of the Company's outstanding common stock, or any . . .
Item 3.02 Unregistered Sales of
The information contained in Item 1.01 of this Current Report on Form 8-K in relation to the Inducement Warrants and the shares of the Company's common stock issuable upon the exercise thereof is hereby incorporated by reference into this Item 3.02. The Inducement Warrants were issued in reliance upon an exemption from registration pursuant to 4(a)(2) under the Securities Act of 1933, as amended, and Rule 506 of Regulation D promulgated thereunder.
Item 3.03 Material Modifications to Rights of Security Holders.
The disclosure set forth under Item 1.01 is incorporated herein by reference into this Item 3.03 in its entirety.
Item 5.03 Amendment to Articles of Incorporation or Bylaws; Change in Fiscal
Year.
On
Copies of the Certificate of Elimination of Series A Convertible Preferred Stock, the Certificate of Elimination of Series B-1 Convertible Preferred Stock and the Certificate of Elimination of Series B-2 Convertible Preferred Stock are filed herewith as Exhibits 3.1, 3.2 and 3.3, respectively, and are incorporated by reference into this Item 5.03.
Item 9.01 Financial Statements and Exhibits
(d) Exhibits
Exhibit
No. Description
3.1 Certificate of Elimination of Series A Convertible Preferred Stock,
filed with the Delaware Secretary of State on June 22, 2021
3.2 Certificate of Elimination of Series B-1 Convertible Preferred
Stock, filed with the Delaware Secretary of State on June 22, 2021
3.3 Certificate of Elimination of Series B-2 Convertible Preferred
Stock, filed with the Delaware Secretary of State on June 22, 2021
4.1 Form of Inducement Warrant
10.1 Form of Inducement Letter
--------------------------------------------------------------------------------
© Edgar Online, source
